Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis

INIS

• availability 10%
• birth 10%
• children 50%
• comparative evaluations 10%
• congenital diseases 30%
• evaluation 10%
• hearings 70%
• infants 40%
• losses 50%
• safety 10%
• testing 20%
• therapy 20%

Medicine and Dentistry

• Absence 10%
• Age 10%
• Antimicrobial Therapy 10%
• Bilateral Hearing Loss 10%
• Brain Stem Response 10%
• Childbirth 10%
• Combination Therapy 10%
• Congenital Toxoplasmosis 30%
• Ethinylestradiol Plus Megestrol Acetate 10%
• Evaluation Study 10%
• Follow up 10%
• Hearing 10%
• Hearing Impairment 30%
• Incidence 20%
• Infant 80%
• Otitis Media 10%
• Sensorineural Hearing Loss 30%

Nursing and Health Professions

• Absence 10%
• Antimicrobial Therapy 10%
• Child 100%
• Combination Therapy 10%
• Congenital Toxoplasmosis 30%
• Ethinylestradiol Plus Megestrol Acetate 10%
• Evaluation Study 10%
• Follow up 10%
• Hearing Impairment 10%
• Incidence 20%
• Otitis Media 10%
• Pilot Study 10%